Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?

In 1906 Alois Alzheimer, described the cerebral lesions characteristic of the disorder that received his name: senile plaques and neurofibrillary tangles. Alzheimer's disease (AD) is now, 100 years after, the most prevalent form of dementia in the world. The longer life expectancy and aging of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Behrens P,María Isabel, Vergara E,Fernando
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2007
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000100015
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872007000100015
record_format dspace
spelling oai:scielo:S0034-988720070001000152014-01-06Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?Behrens P,María IsabelVergara E,Fernando Alzheimer disease Immunoglobulins, intravenous Positron-emission tomography Senile plaques In 1906 Alois Alzheimer, described the cerebral lesions characteristic of the disorder that received his name: senile plaques and neurofibrillary tangles. Alzheimer's disease (AD) is now, 100 years after, the most prevalent form of dementia in the world. The longer life expectancy and aging of the population renders it as a serious public health problem of the future. Urgent methods of diagnosis and treatment are required, since the definitive diagnosis of AD continues to be neuropathologic. In the last 30 years several drugs have been approved to retard the progression of the disease; however, there are still no curative or preventive treatments. Although still in experimentation, the visualization of amyloid deposition by positron emission tomography or magnetic resonance imaging will allow in vivo diagnosis of AD. In addition, experiments with the amyloid vaccine are still ongoing, and very recent data suggest that intravenous gammaglobulins may be beneficial and safe for the treatment of ADinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.135 n.1 20072007-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000100015es10.4067/S0034-98872007000100015
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Alzheimer disease
Immunoglobulins, intravenous
Positron-emission tomography
Senile plaques
spellingShingle Alzheimer disease
Immunoglobulins, intravenous
Positron-emission tomography
Senile plaques
Behrens P,María Isabel
Vergara E,Fernando
Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
description In 1906 Alois Alzheimer, described the cerebral lesions characteristic of the disorder that received his name: senile plaques and neurofibrillary tangles. Alzheimer's disease (AD) is now, 100 years after, the most prevalent form of dementia in the world. The longer life expectancy and aging of the population renders it as a serious public health problem of the future. Urgent methods of diagnosis and treatment are required, since the definitive diagnosis of AD continues to be neuropathologic. In the last 30 years several drugs have been approved to retard the progression of the disease; however, there are still no curative or preventive treatments. Although still in experimentation, the visualization of amyloid deposition by positron emission tomography or magnetic resonance imaging will allow in vivo diagnosis of AD. In addition, experiments with the amyloid vaccine are still ongoing, and very recent data suggest that intravenous gammaglobulins may be beneficial and safe for the treatment of AD
author Behrens P,María Isabel
Vergara E,Fernando
author_facet Behrens P,María Isabel
Vergara E,Fernando
author_sort Behrens P,María Isabel
title Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
title_short Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
title_full Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
title_fullStr Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
title_full_unstemmed Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
title_sort cien años de la enfermedad de alzheimer: la inmunoterapia ¿una esperanza?
publisher Sociedad Médica de Santiago
publishDate 2007
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000100015
work_keys_str_mv AT behrenspmariaisabel cienanosdelaenfermedaddealzheimerlainmunoterapiaunaesperanza
AT vergaraefernando cienanosdelaenfermedaddealzheimerlainmunoterapiaunaesperanza
_version_ 1718436303247245312